ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

CCIRC Report Suggests Ways To Enhance Role Of Surgeons

July 22, 1977

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012

Schmidt’s Advice To Upton: Take A Look At grants Vs. Contracts, Carcinogenesis, Cancer Control

July 1, 1977